Aurora Cannabis (TSE:ACB) Trading Up 0.5%

Aurora Cannabis Inc. (TSE:ACB)’s share price was up 0.5% during mid-day trading on Tuesday . The company traded as high as C$10.70 and last traded at C$10.70. Approximately 1,289,997 shares changed hands during trading, a decline of 70% from the average daily volume of 4,363,038 shares. The stock had previously closed at C$10.65.

ACB has been the topic of several recent analyst reports. Stifel Nicolaus raised their target price on shares of Aurora Cannabis from C$6.50 to C$7.80 in a report on Friday, February 12th. Jefferies Financial Group upped their price target on shares of Aurora Cannabis from C$4.59 to C$9.44 in a report on Wednesday, February 24th. Canaccord Genuity upped their price target on shares of Aurora Cannabis from C$11.00 to C$14.00 in a report on Friday, February 12th. CIBC upped their price target on shares of Aurora Cannabis to C$18.50 and gave the stock an “underperform” rating in a report on Tuesday, February 16th. Finally, MKM Partners reaffirmed a “sell” rating on shares of Aurora Cannabis in a report on Friday, February 12th. Three research analysts have rated the stock with a sell rating and five have given a hold rating to the company. The company has an average rating of “Hold” and a consensus price target of C$11.91.

The firm has a market cap of C$2.12 billion and a P/E ratio of -0.55. The company has a debt-to-equity ratio of 22.46, a quick ratio of 3.11 and a current ratio of 4.96. The company’s 50 day moving average is C$11.15 and its 200 day moving average is C$12.00.

Aurora Cannabis (TSE:ACB) last issued its quarterly earnings data on Thursday, February 11th. The company reported C($0.36) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of C($0.23) by C($0.13). The company had revenue of C$67.67 million for the quarter, compared to analyst estimates of C$69.12 million. On average, equities research analysts anticipate that Aurora Cannabis Inc. will post -0.61 EPS for the current year.

In other Aurora Cannabis news, Director Michael Singer sold 25,000 shares of the company’s stock in a transaction that occurred on Friday, February 19th. The shares were sold at an average price of C$15.58, for a total value of C$389,500.00. Following the completion of the transaction, the director now directly owns 1,777 shares in the company, valued at approximately C$27,685.66.

Aurora Cannabis Company Profile (TSE:ACB)

Aurora Cannabis Inc produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Story: Gross Domestic Product (GDP)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with's FREE daily email newsletter.